Aridis Pharmaceuticals Inc (ARDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,666 | -8,757 | -7,334 | -24,656 | -19,712 |
| Depreciation Amortization | 200 | 124 | 51 | 62 | 24 |
| Accounts receivable | -800 | 0 | N/A | N/A | 67 |
| Accounts payable and accrued liabilities | 827 | -55 | N/A | N/A | N/A |
| Other Working Capital | 1,394 | 92 | 2,305 | 277 | 417 |
| Other Operating Activity | -376 | -2,111 | 541 | 6,760 | 5,810 |
| Operating Cash Flow | $-15,421 | $-10,707 | $-4,437 | $-17,557 | $-13,394 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -677 | -919 | -272 | -698 | -410 |
| Investing Cash Flow | $-677 | $-919 | $-272 | $-698 | $-410 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 25,079 | 0 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 21,060 | 21,060 |
| Financing Cash Flow | $25,079 | $0 | $N/A | $21,060 | $21,060 |
| Beginning Cash Position | 25,096 | 25,096 | 25,096 | 22,291 | 22,291 |
| End Cash Position | 34,077 | 13,470 | 20,387 | 25,096 | 29,547 |
| Net Cash Flow | $8,981 | $-11,626 | $-4,709 | $2,805 | $7,256 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,421 | -10,707 | -4,437 | -17,557 | -13,394 |
| Capital Expenditure | -677 | -919 | -272 | N/A | -410 |
| Free Cash Flow | -16,098 | -11,626 | -4,709 | -17,557 | -13,804 |